Quoin Pharmaceuticals, Ltd. (QNRX)
NASDAQ: QNRX · Real-Time Price · USD
0.2116
-0.0176 (-7.68%)
At close: Apr 1, 2025, 4:00 PM
0.2175
+0.0059 (2.79%)
After-hours: Apr 1, 2025, 5:05 PM EDT
Quoin Pharmaceuticals Market Cap
Quoin Pharmaceuticals has a market cap or net worth of $4.36 million as of April 1, 2025. Its market cap has increased by 17.73% in one year.
Market Cap
4.36M
Enterprise Value
-6.75M
1-Year Change
17.73%
Ranking
Category
Stock Price
$0.21
Market Cap Chart
Since August 1, 2016, Quoin Pharmaceuticals's market cap has decreased from $28.60M to $4.36M, a decrease of -84.77%. That is a compound annual growth rate of -19.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2025 | 4.60M | 39.39% |
| Dec 31, 2024 | 3.30M | -31.25% |
| Dec 29, 2023 | 4.80M | -30.43% |
| Dec 30, 2022 | 6.90M | -54.61% |
| Dec 31, 2021 | 15.20M | 80.95% |
| Dec 31, 2020 | 8.40M | 68.00% |
| Dec 31, 2019 | 5.00M | -60.32% |
| Dec 31, 2018 | 12.60M | -66.58% |
| Dec 29, 2017 | 37.70M | 125.75% |
| Dec 30, 2016 | 16.70M | -41.61% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.37B |
| UnitedHealth Group | 479.04B |
| Johnson & Johnson | 399.67B |
| AbbVie | 370.55B |
| Novo Nordisk | 305.46B |
| Abbott Laboratories | 230.04B |
| Merck & Co. | 226.69B |
| AstraZeneca | 225.46B |